Related Experiment Video
Updated: Mar 23, 2026

10:38
Synthesis of Functionalized 10-nm Polymer-coated Gold Particles for Endothelium Targeting and Drug Delivery
Published on: January 15, 2018
13.2K
Gold nanoparticle surface functionalization: mixed monolayer versus hetero bifunctional peg linker
Nanomedicine (London, England)
|March 30, 2016
Summary
Functionalizing gold nanoparticles (AuNPs) for clinical use is challenging. This review compares mixed monolayers and hetero-bifunctional linkers for cofunctionalizing AuNPs, finding mixed monolayers more established in preclinical studies.
Area of Science:
- Nanotechnology
- Biomedical Engineering
- Surface Chemistry
Background:
- Clinically relevant gold nanoparticle (AuNP) treatments require surface functionalization with multiple ligands like drugs and targeting moieties.
- Attaching diverse ligands while maintaining their biological function presents a significant challenge in AuNP development.
- Co-functionalizing AuNP surfaces is crucial for advanced therapeutic applications.
Purpose of the Study:
- To compare mixed monolayers and hetero-bifunctional linkers for AuNP surface cofunctionalization.
- To evaluate the relative merits and current understanding of these two cofunctionalization methods.
- To provide insights into the effectiveness of different surface arrangements for AuNP-based therapies.
Main Methods:
- Review of existing literature on AuNP surface cofunctionalization techniques.
- Comparison of mixed monolayer and hetero-bifunctional linker strategies.
- Analysis of in vitro, animal, and preclinical study findings.
Main Results:
- Both mixed monolayers and hetero-bifunctional linkers are widely employed for AuNP cofunctionalization.
- Mixed monolayer functionalization has demonstrated effectiveness in animal and preclinical studies.
- In vitro studies show promise for PEG linker capped AuNPs, but their full benefits are not yet understood.
Conclusions:
- There is limited consensus on the relative advantages of mixed monolayers versus hetero-bifunctional linkers for AuNP cofunctionalization.
- Mixed monolayers appear more validated in preclinical settings for AuNP therapeutic development.
- Further research is needed to fully elucidate the potential of linker-based strategies like PEG-capped AuNPs.

